Tumor stiffness as an imaging biomarker of tyrosine kinase inhibitor response: A preclinical study
{{output}}
Objective: Tyrosine kinase inhibitors (TKIs), such as sorafenib, are standard therapies for advanced hepatocellular carcinoma (HCC), but their biomechanical impact and the role of magnetic resonance elastography (MRE) in treatmen... ...
